Geneos Wealth Management Inc. Repligen Corp Transaction History
Geneos Wealth Management Inc.
- $3.92 Billion
- Q2 2025
A detailed history of Geneos Wealth Management Inc. transactions in Repligen Corp stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 146 shares of RGEN stock, worth $21,666. This represents 0.0% of its overall portfolio holdings.
Number of Shares
146
Previous 166
12.05%
Holding current value
$21,666
Previous $21,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding RGEN
# of Institutions
506Shares Held
58.9MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.12 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$980 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$753 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$284 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$241 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.23B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....